Cognetivity Neurosciences Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Cognetivity Neurosciences Ltd is a Canadian healthcare technology company focused on developing diagnostic tools for early detection of cognitive decline. The company’s platform uses artificial intelligence and digital testing methods to assess brain health in clinical and non-clinical environments. Its technology is targeted for applications in neurology, psychiatry, and general health screening. Cognetivity Neurosciences Ltd is headquartered in Vancouver, Canada, and its shares are listed on the CSE.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
CGN
Country
🇨🇦 Canada